Dr. Chika Anekwe is an obesity medicine physician at Harvard and debates the implications of using Ozempic for weight loss alongside Dr. Vinay Prasad, a hematologist-oncologist and policy expert. They delve into the controversy surrounding obesity as a disease versus a lifestyle choice. Meanwhile, Calley Means critiques industry practices and promotes healthier food policies. The trio tackles ethical dilemmas in pediatric obesity treatment and explores the effectiveness of Ozempic against deeper health issues, opening a lively discussion on our food and medical systems.
01:18:46
forum Ask episode
web_stories AI Snips
view_agenda Chapters
menu_book Books
auto_awesome Transcript
info_circle Episode notes
question_answer ANECDOTE
Celebrity Ozempic Use
Celebrities like Chelsea Handler and Elon Musk admit to using Ozempic.
Social media influencers showcase dramatic before-and-after photos.
insights INSIGHT
Ethical Concerns
Ozempic's off-label use for weight loss raises ethical questions.
There's a difference between its use for morbid obesity and for aesthetic purposes.
volunteer_activism ADVICE
How Ozempic Works
Ozempic, or semaglutide, mimics a natural hormone to promote fullness.
It slows gastric emptying, reducing appetite and food intake.
Get the Snipd Podcast app to discover more snips from this episode
How Bad Policy and Bad Evidence Harm People with Cancer
Vinayak K. Prasad, MD, MPH
In 'Malignant', Dr. Vinayak K. Prasad critiques the current state of oncology, highlighting issues such as lax regulatory standards, financial conflicts of interest, and the overemphasis on surrogate endpoints in clinical trials. He argues for reforms to ensure that cancer drugs provide meaningful benefits at lower costs. The book offers insights into how cancer trials are conducted and how drugs are approved, proposing solutions to improve cancer medicine.
Ozempic, the brand name drug for a medication called semaglutide, is one of the most popular drugs on the market right now. Originally developed to treat type 2 diabetes, the injectable drug has recently boomed in popularity for its off-label use to help people lose weight... fast. Celebrities and public figures have admitted they're taking it. Instagram influencers are showing off remarkable before and after photos. It's been called "TikTok's favorite weight loss drug." As one doctor said, "we haven't seen a prescription drug with this much cocktail and dinner chatter since Viagra came to the market."
But alongside the rise in Ozempic prescriptions come many questions still unknown: Who should be taking it? Is it safe for longterm use? Who is it safe for? Should children be prescribed it to treat childhood obesity, as the American Academy of Pediatrics recently advised? Is Ozempic a permanent solution to the obesity epidemic? Or is it more like a bandaid, a quick fix that does little to address the root causes of obesity? And, to that end, what is the root cause of obesity? Is it a "brain disease," as one Harvard doctor recently declared on 60 Minutes that warrants medication? Or do diet, exercise, willpower and other behavioral lifestyle choices still matter?
These are questions that my guests do not agree on. Dr. Chika Anekwe is an obesity medicine physician at Massachusetts General Hospital and an instructor in medicine at Harvard Medical School. Dr. Vinay Prasad is a hematologist-oncologist and a professor at the University of California San Francisco. His most recent book is Malignant: How Bad Policy and Bad Evidence Harm People with Cancer.And Calley Means is a former consultant for food and Pharma companies who now works to expose their practices and instead incentive healthy food as the foundation of health policy.
Today, Dr. Anekwe, Dr. Prasad, and Means debate: will Ozempic solve obesity in America?
Honestly with Bari Weiss 
